CNBX (CNBX Pharmaceuticals) FCF Margin %: 0.00% (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CNBX Pharmaceuticals FCF Margin %?

CNBX Pharmaceuticals CNBX +33.33% FCF Margin % is 0.00% as of May. 2026. The stock has 3 warning signs investors should review. Among 956 Biotechnology companies, CNBX Pharmaceuticals ranks worse than 104602.41% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CNBX Pharmaceuticals's Free Cash Flow for the three months ended in May. 2026 was $-0.05 Mil. CNBX Pharmaceuticals's Revenue for the three months ended in May. 2026 was $0.00 Mil. Therefore, CNBX Pharmaceuticals's FCF Margin % for the quarter that ended in May. 2026 was 0.00%.

As of today, CNBX Pharmaceuticals's current FCF Yield % is -48.29%.

The historical rank and industry rank for CNBX Pharmaceuticals's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of CNBX Pharmaceuticals was -27.56%. The lowest was -40728.57%. And the median was -11051.67%.

CNBX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -80.565
* Ranked among companies with meaningful FCF Margin % only.

CNBX Pharmaceuticals FCF Margin % Related Terms

CNBX Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for CNBX Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNBX Pharmaceuticals FCF Margin % Chart

CNBX Pharmaceuticals Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -5,603.33 -27.56 -188.46 0.00

CNBX Pharmaceuticals Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNBX vs SIGY, LIPO, CARM: FCF Margin % Comparison

For the Biotechnology subindustry, CNBX Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's FCF Margin % falls into.


CNBX Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CNBX Pharmaceuticals's FCF Margin for the fiscal year that ended in Aug. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-0.171/0
= %

CNBX Pharmaceuticals's FCF Margin for the quarter that ended in May. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: May. 2026 )/Revenue (Q: May. 2026 )
=-0.048/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
CNBX Pharmaceuticals (CNBX) has a FCF Margin % of 0.00% as of May. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CNBX Pharmaceuticals and its competitors. According to the industry distribution chart, CNBX Pharmaceuticals ranks #999999 out of 956 companies in the Biotechnology industry.
Is CNBX Pharmaceuticals' FCF Margin % too high?
CNBX Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, CNBX Pharmaceuticals ranks #999999 out of 956 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does CNBX Pharmaceuticals' FCF Margin % compare to SIGY and LIPO?
According to the Biotechnology industry distribution chart, CNBX Pharmaceuticals ranks #999999 out of 956 companies for FCF Margin %. This places CNBX Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CNBX Pharmaceuticals and its competitors. CNBX Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNBX Pharmaceuticals stock overvalued right now?
CNBX Pharmaceuticals (CNBX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CNBX Pharmaceuticals (CNBX), the current FCF Margin % is 0.00% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CNBX Pharmaceuticals Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.